Company

Mirna Therapeutics, Inc.

Mirna Therapeutics develops microRNA-based therapeutics for liver cancer and blood malignancies, based in Austin, US.

About

Mirna Therapeutics, Inc. is a biopharmaceutical company developing microRNA-based therapeutics for liver cancer and hematological malignancies. Founded in 2007 and based in Austin, Texas, it raised USD 41.8 million in a Series D led by Baxter Ventures in April 2015, with participation from Eastern Capital, Santé Ventures, Morningside Ventures, Rock Springs Capital and Celgene Corporation. The company became public in 2015, raising USD 43.8 million, and merged with Synlogic, Inc. in May 2017.

3Funding rounds

9Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in